Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais State, Brazil.
Hematology Unit, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais State, Brazil.
Thromb Res. 2019 Jun;178:85-90. doi: 10.1016/j.thromres.2019.04.008. Epub 2019 Apr 10.
Cerebral venous thrombosis (CVT), although rare, is potentially fatal. Few studies have investigated risk factors associated with recurrent venous thromboembolism (VTE) after a first CVT event of which most are from Caucasian populations. The aim of this study was to evaluate risk factors associated with recurrent VTE after a first CVT event in a South American-population.
PATIENTS/METHODS: In this cohort, multicenter study, patients aged >18 years and objectively-diagnosed with CVT were included, with follow-up starting after discontinuing anticoagulant therapy. The primary outcome was symptomatic VTE recurrence at any venous site.
We included 203 patients with a median age of 30.8 (interquartile range [IQR], 24.7-40.9) years and a follow-up of 3.0 (IQR, 1.2-5.6) years. Most patients (86.2%) were women, and among those of reproductive age (n = 162), 65.4% developed CVT during oral contraceptive use, and 9.2% during pregnancy/puerperium. Thirteen patients (6.9%) developed VTE recurrence after a first CVT, yielding an overall rate of 1.6/100 patient-years (95% confidence interval [CI], 0.8-2.8). Recurrence rate was higher in males (4.6/100 patient-years; 95% CI, 1.2-11.7) than in females (1.2/100 patient-years; 95% CI, 0.6-2.4), and in patients with factor V Leiden mutation (9.2/100 patient-years; 95% CI, 1.1-33.1) than in those without it (1.2/100 patient-years; 95% CI, 0.5-2.4).
VTE recurrence after a first CVT was low. In spite of the limitation of small sample size, male sex and factor V Leiden mutation were the only factors associated with a significant higher risk of recurrent VTE after a first CVT in a multivariate analysis.
尽管脑静脉血栓形成(CVT)很少见,但它可能是致命的。很少有研究调查过首次 CVT 事件后复发性静脉血栓栓塞症(VTE)的相关风险因素,其中大多数来自白种人群。本研究的目的是评估南美人群中首次 CVT 事件后复发性 VTE 的相关风险因素。
患者/方法:在这项多中心队列研究中,纳入了年龄>18 岁且经客观诊断为 CVT 的患者,在停止抗凝治疗后开始随访。主要结局是任何静脉部位的症状性 VTE 复发。
我们纳入了 203 例患者,中位年龄为 30.8 岁(四分位距[IQR],24.7-40.9),随访时间为 3.0 年(IQR,1.2-5.6)。大多数患者(86.2%)为女性,在有生育能力的年龄组(n=162)中,65.4%在使用口服避孕药时发生 CVT,9.2%在妊娠/产褥期发生 CVT。首次 CVT 后有 13 例(6.9%)患者发生 VTE 复发,总复发率为 1.6/100 患者年(95%可信区间[CI],0.8-2.8)。男性的复发率(4.6/100 患者年;95%CI,1.2-11.7)高于女性(1.2/100 患者年;95%CI,0.6-2.4),且携带因子 V 莱顿突变的患者(9.2/100 患者年;95%CI,1.1-33.1)高于未携带该突变的患者(1.2/100 患者年;95%CI,0.5-2.4)。
首次 CVT 后 VTE 复发率较低。尽管样本量小存在局限性,但多变量分析显示,男性和因子 V 莱顿突变是首次 CVT 后复发性 VTE 的唯一显著相关危险因素。